Qiu Yu, Zhao Fengyi, Zheng Xiyin, Wang Xiaohua
The Department of Clinical Nutrition, Nantong First People's Hospital, Nantong, Jiangsu, China.
The Department of Clinical Nutrition, Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu, China.
Front Nutr. 2025 Mar 26;12:1535190. doi: 10.3389/fnut.2025.1535190. eCollection 2025.
Sarcopenia has emerged as a global health concern, but the association between dietary vitamin levels and sarcopenia is not elucidated. This study aims to shed light on the link of 11 dietary vitamins to the risk of sarcopenia in adults at the age of 20-59.
This cross-sectional study encompassed 2011-2018 data from the National Health and Nutrition Examination Survey (NHANES) for adults aged 20-59. Sarcopenia was defined through the appendicular lean mass to body mass index ratio calculated via Dual-Energy X-ray Absorptiometry (DXA), with sarcopenia determined as a ratio of <0.789 for the male and <0.512 for the female. Multivariate weighted logistic regression assisted in assessing the connection of dietary vitamins with sarcopenia, with results presented as odds ratios (ORs) and 95% confidence intervals (CIs). The dose-response association of various vitamins with sarcopenia was visualized through restricted cubic splines (RCS). Subgroup analyses were carried out to examine the consistency of the aforementioned associations. Sensitivity analysis was performed utilizing propensity score matching (PSM) to adjust for confounding factors and enhance the robustness of the results.
Among the 7,864 participants, 677 (8.6%) had sarcopenia, and 7,187 (91.4%) did not. Multivariate weighted logistic regression and RCS analyses indicated that higher intakes of VA, VB1, VB2, VB3, VB6, VB9, VB12, VC, VE, and VK were notably linked to a lowered risk of sarcopenia ( < 0.05). Among these, VA, VC, and VE exhibited a non-linear negative association with sarcopenia risk ( for non-linear < 0.05), while VB1, VB2, VB3, VB6, VB9, VB12, and VK exhibited a linear negative association ( for non-linear > 0.05). Subgroup analysis yielded largely consistent results. After confounding factors were adjusted through PSM, the results suggest that the intake of VA, VB2, VB6, and VC remains significantly associated with a lowered risk of sarcopenia ( < 0.05).
Higher dietary levels of VA, VB2, VB6, and VC are significantly related to a lower livelihood of sarcopenia. These findings provide new evidence and insights for early dietary interventions aimed at preventing sarcopenia.
肌肉减少症已成为全球关注的健康问题,但膳食维生素水平与肌肉减少症之间的关联尚未阐明。本研究旨在揭示11种膳食维生素与20 - 59岁成年人肌肉减少症风险之间的联系。
这项横断面研究纳入了2011 - 2018年美国国家健康与营养检查调查(NHANES)中20 - 59岁成年人的数据。通过双能X线吸收法(DXA)计算的四肢瘦体重与体重指数之比来定义肌肉减少症,男性肌肉减少症的判定标准为该比值<0.789,女性为<0.512。多变量加权逻辑回归用于评估膳食维生素与肌肉减少症之间的关联,结果以比值比(OR)和95%置信区间(CI)表示。通过受限立方样条(RCS)直观呈现各种维生素与肌肉减少症的剂量反应关系。进行亚组分析以检验上述关联的一致性。利用倾向得分匹配(PSM)进行敏感性分析,以调整混杂因素并增强结果的稳健性。
在7864名参与者中,677人(8.6%)患有肌肉减少症,7187人(91.4%)未患。多变量加权逻辑回归和RCS分析表明,较高的维生素A、硫胺素(VB1)、核黄素(VB2)、烟酸(VB3)、吡哆醇(VB6)、叶酸(VB9)、钴胺素(VB12)、维生素C、维生素E和维生素K摄入量与较低的肌肉减少症风险显著相关(<0.05)。其中,维生素A、维生素C和维生素E与肌肉减少症风险呈非线性负相关(非线性检验<0.05),而硫胺素(VB1)、核黄素(VB2)、烟酸(VB3)、吡哆醇(VB6)、叶酸(VB9)、钴胺素(VB12)和维生素K呈线性负相关(非线性检验>0.05)。亚组分析得出的结果基本一致。通过PSM调整混杂因素后,结果表明维生素A、核黄素(VB2)、吡哆醇(VB6)和维生素C的摄入量仍与较低的肌肉减少症风险显著相关(<0.05)。
较高的膳食维生素A、核黄素(VB2)、吡哆醇(VB6)和维生素C水平与较低的肌肉减少症发生率显著相关。这些发现为旨在预防肌肉减少症的早期膳食干预提供了新的证据和见解。